drugset / Trial / NCT05892770

Zinc Supplementation Prior to Botox Injections for Spasmodic Dysphonia

NCT05892770

Phase 1/2 Active not recruiting 36 enrolled University of Florida
Non-randomizedSingle-groupOpen-labelTreatment

Summary

One initial study has shown that Botulinum Toxin (BT) in combination with zinc supplementation may increase the duration of effects BT treatment. This initial study was in the context of facial aesthetics. The purpose of the present study is to determine the effect, if any, of oral zinc supplementation prior to BT in the treatment of spasmodic dysphonia. If positive effects will be observed, this would help reduce the burden of disease for these patients.

Timeline

Start
2023-08-01
Primary completion
2025-12
Completion
2025-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Zinc gluconate Small molecule 50 mg
Background Botulinum toxin type A Protein / enzyme biologic Intramuscular

Indications